Labetalol hydrochloride
Labetalol Hydrochloride is a generic prescription medication available as oral tablets in 100mg, 200mg, and 300mg strengths. Manufactured by Endo USA, Inc., it acts as a beta-adrenergic blocker to help manage high blood pressure. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | Labetalol Hydrochloride is a generic prescription medication available as oral tablets in 100mg, 200mg, and 300mg strengths. Manufactured by Endo USA, Inc., it acts as a beta-adrenergic blocker to help manage high blood pressure. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Labetalol hydrochloride", "mediaType": "text/html", "description": " Access the FDA dataset for Labetalol hydrochloride — ANDA 074787 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=074787" } ] |
| identifier | ANDA074787 |
| issued | 2016-09-16 |
| keyword |
[ "drug-information", "fda", "pharmaceuticals", "prescription-drugs", "public-health" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Labetalol hydrochloride |
